Peking University Care Luzhong Hospital
11
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
55%
6 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects
Role: collaborator
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
Role: collaborator
AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
Role: collaborator
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Role: collaborator
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
Role: collaborator
Evaluation of Antithrombotic STrategies in STEMI Patients in China
Role: collaborator
All 11 trials loaded